MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.97
-0.03 (-0.18%)
Mar 19, 2026, 4:00 PM EDT - Market closed
MediWound Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MediWound stock has a target of 36, which predicts a 112.14% increase from the current stock price of 16.97.
Price Target: $36 (+112.14%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 21, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for MediWound is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $31 → $36 | Strong Buy | Maintains | $31 → $36 | +112.14% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $31 | Strong Buy | Maintains | $25 → $31 | +82.68% | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +47.32% | Mar 20, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +129.82% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +47.32% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
26.73M
from 16.96M
Increased by 57.63%
Revenue Next Year
33.80M
from 26.73M
Increased by 26.44%
EPS This Year
-2.47
from -2.10
EPS Next Year
-2.24
from -2.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 31.5M | 35.9M | |||
| Avg | 26.7M | 33.8M | |||
| Low | 24.1M | 30.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 85.7% | 34.3% | |||
| Avg | 57.6% | 26.4% | |||
| Low | 42.0% | 15.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.04 | -1.63 | |||
| Avg | -2.47 | -2.24 | |||
| Low | -3.14 | -2.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.